Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular risk indices and insulin resistance in impaired glucose tolerance vs polycystic ovarian syndrome, modified by metformin or pioglitazone
2005-000435-18Phase 4Completed
- Sponsor
- University of Hull
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of metformin and pioglitazone in prediabetes and polycystic ovary syndrome (PCOS) (4 arms), sponsored by University of Hull. Primary endpoints: Change in insulin resistance and Change in endothelial function. Started Feb 2005; status: completed.
02
Drugs
metforminpioglitazone
03
Conditions
prediabetespolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on 2005-000435-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000435-18.